Diana Ernst, RPh

Most recent articles by Diana Ernst, RPh

NIH trial evaluating hydroxychloroquine for COVID-19 underway
NIH trial evaluating hydroxychloroquine for COVID-19 underway
Diana Ernst, RPh
April 13, 2020
11:45 am

The intervention arm will receive hydroxychloroquine in addition to supportive care.

Abbott’s point-of-care COVID-19 test delivers results within minutes
Abbott’s point-of-care COVID-19 test delivers results within minutes
Diana Ernst, RPh
March 31, 2020
12:07 pm

The Abbott ID NOW COVID-19 tests runs on the ID NOW platform and delivers results within minutes.

FDA takes additional action to expedite availability of COVID-19 tests
FDA takes additional action to expedite availability of COVID-19 tests
Diana Ernst, RPh
March 13, 2020
1:31 pm

The Food and Drug Administration has announced that it will not object to the New York State Department of Health authorizing certain laboratories in New York to start testing patients for coronavirus disease 2019 once the tests have been validated.

FDA, FTC crack down on fraudulent COVID-19 ‘treatments’
FDA, FTC crack down on fraudulent COVID-19 ‘treatments’
Diana Ernst, RPh
March 12, 2020
3:44 pm

Unapproved products are being marketed as coronavirus 2019 cures

  • From Our Partners